<DOC>
	<DOC>NCT00441545</DOC>
	<brief_summary>To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.</brief_summary>
	<brief_title>Head to Head Study Against Sevelamer Hydrochloride</brief_title>
	<detailed_description>To compare the efficacy of Fosrenol (Lanthanum carbonate) and sevelamer hydrochloride in the reduction of serum phosphorus levels from baseline.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Sevelamer</mesh_term>
	<criteria>Adults with end stage renal disease who are receiving dialysis Subjects with significant gastrointestinal disorders Subjects who are pregnant or nursing Subjects currently taking lanthanum carbonate, sevelamer hydrochloride, cinacalcet hydrochloride Subjects who are HIV positive Subjects with clinical significant liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>